Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxycodone DART
- Development stage
- Preclinical
- Lead developer
- Lehigh Valley Technologies
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Oxycodone DART is an abuse-resistant formulation of the opioid agonist oxycodone, developed by Lehigh Valley Technologies using its proprietary Diversion and Abuse Resistant Technologies (DART) platform. As a small molecule analgesic, oxycodone acts primarily as an agonist at the mu-opioid receptor (OPRM1) within the central nervous system, effectively managing moderate to severe pain. The DART technology is engineered to provide physical and chemical barriers that deter common methods of tampering and abuse, such as crushing for insufflation or extraction for intravenous injection. This formulation aims to maintain the therapeutic benefits of oxycodone while reducing the potential for non-medical use and diversion, addressing a critical need in the pain management landscape.
- Other names
- Oxycodone (abuse-resistant/DART)oxycodone DART abuse-resistant formulation
02
Targets
KOR (Kappa opioid receptor)DOR (Opioid Receptor Delta 1)MOR (Mu opioid receptor)
Beyond the preview
Go deeper on Oxycodone DART.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oxycodone DART.